INOVIO Pharmaceuticals, Inc.

About INOVIO Pharmaceuticals, Inc.

INOVIO Pharmaceuticals is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer, and infectious diseases. They aim to change treatment paradigms and improve lives through innovative, next-generation therapies using proprietary technology for designing DNA plasmids and delivery devices like CELLECTRA(r).

Products & Services

DNA Medicines:Innovative therapies targeting HPV-related diseases, cancer, and infectious diseases using DNA plasmids that instruct the body to produce disease-fighting proteins.

CELLECTRA(r) Devices:Proprietary investigational devices designed to deliver DNA plasmids into cells for optimal effect without chemical adjuvants, lipid nanoparticles, or viral vectors.

Specialties

DNA Medicines HPV-related Diseases Cancer Treatment Infectious Diseases In Vivo Protein Production Optimized Plasmid Design and Delivery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-11-11 FD: 2025-11-11	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-07-03 FD: 2025-07-03	2 investors
3	RT: Public Offering T: - FT: Public Offering	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2024-12-13 FD: 2024-12-13	3 investors
4	RT: Underwritten Offering T: - FT: Underwritten Offering	A: 36000000 MR: - FA: approximately $36 million FAN: 36000000	D: 2024-04-15 FD: 2024-04-15	1 investors

Public Offering Latest

2025-11-11

$25.0M

1 investor (Pro only)

Public Offering 2025-07-03

$25.0M

Public Offering 2024-12-13

$30.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jacqueline Shea

President & Chief Executive Officer

P

Peter Kies

Chief Financial Officer

M

Michael Sumner

Chief Medical Officer

L

Laurent Humeau

Chief Scientific Officer; Chairman, Scientific Advisory Board

S

Steve Egge

Chief Commercial Officer

R

Rob Crotty

General Counsel, Corporate Secretary & Chief Compliance Officer

View 17 more team members with Pro

Unlock Full Team Directory

Recent News